Asthma Therapeutics in Asia-Pacific Markets to 2023 - High Prevalence and Highly Priced Existing & Upcoming Biologics will Drive the Market

Market: Pharmaceuticals and Healthcare

Asia Pacific, 134 pages report, published by GBI Research

Report ThumbnailJune-2017
Asthma Therapeutics in Asia-Pacific Markets to 2023 - High Prevalence and Highly Priced Existing & Upcoming Biologics will Drive the Market

Summary

Asthma is a common chronic inflammatory disease of the airways, characterized by recurrent attacks of breathlessness and wheezing, which vary in frequency and severity from patient to patient. The exact causes of asthma are currently unknown, and may be the result of a combination of factors, although two major factors thought to be involved are en

Read More
  • 1.2 List of Figures
  • Figure 1: Asthma Therapeutics Market, Comparative Efficacy and Safety Heatmap for Marketed Products 38
  • Figure 2: Asthma Therapeutics Market, Global, Pipeline, 2016 41
  • Figure 3: Asthma Therapeutics Market, Global, Pipeline by Molecular Target, 2016 44
  • Figure 4: Asthma Therapeutics Market, Global, Pipeline by Molecular Target and Stage of Development, 2016 45
  • Figure 5: Asthma Therapeutics Market, Asia-Pacific, Reslizumab Forecast ($m), 2017-2023 47
  • Figure 6: Asthma Therapeutics
Read More
  • 1.1 List of Tables
  • Table 1: Asthma Therapeutics Market, Global, Classification of Asthma Severity in Children Aged 0-4 15
  • Table 2: Asthma Therapeutics Market, Global, Classification of Asthma Severity in Children Aged 5-11 16
  • Table 3: Asthma Therapeutics Market, Global, Classification of Asthma Severity in Those Aged 12 and over 16
  • Table 4: Asthma Therapeutics Market, Global, Classification of Asthma Severity According to GINA Guidelines (2002) 17
  • Table 5: Asthma Therapeutics, Global, Management
Read More
  • 1 Table of Contents
  • 1 Table of Contents 5
  • 1.1 List of Tables 8
  • 1.2 List of Figures 8
  • 2 Introduction 10
  • 2.1 Disease Introduction 10
  • 2.2 Epidemiology 10
  • 2.3 Symptoms 11
  • 2.4 Etiology and Pathophysiology 11
  • 2.4.1 Pathophysiology 12
  • 2.5 Diagnosis 14
  • 2.6 Disease Stages 15
  • 2.7 Prognosis 17
  • 2.8 Treatment Guidelines and Options 18
  • 2.8.1 Treatment Algorithm 18
  • 2.8.2 Pharmacological Treatments 21
  • 2.8.3 Non-Pharmacological Treatments 25
  • 3 Marketed Products 27
  • 3.1 Overview 27
  • 3.2 ICS for the Maintenance Trea
Read More

Please select a license type

Share

Related Products

GBI ResearchAsthma Therapeutics in Asia-Pacific Markets to 2023 - High Prevalence and Highly Priced Existing & Upcoming Biologics will Drive the MarketProduct ThumbnailAsthma Therapeutics in Asia-Pacific Markets to 2023 - High Prevalence and Highly Priced Existing & Upcoming Biologics will Drive the Market, Industry ReportProduct #: 828987
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2018 Global Market Analyst. All Rights Reserved